|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/7068 | (2006.01) |
| A61K 31/724 | (2006.01) | ||
| A61K 47/48 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1819227 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05853560.0 |
| Date of filing the European patent application | 2005-12-08 | |
| (97) | Date of publication of the European application | 2007-08-22 |
| (45) | Date of publication and mention of the grant of the patent | 2011-02-09 |
| (46) | Date of publication of the claims translation | 2011-05-25 |
| (86) | Number | PCT/US2005/044676 |
| Date | 2005-12-08 |
| (87) | Number | WO 2006/071491 |
| Date | 2006-07-06 |
| (30) | Number | Date | Country code |
| 9540 | 2004-12-10 | US |
| (72) |
TANG, Chunlin, US
JOSHI-HANGAL, Rajashree, US
|
| (73) |
Astex Pharmaceuticals, Inc.,
4420 Rosewood Drive, Suite 200, Pleasanton, CA 94588,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Decitabino farmacinė kompozicija |
| PHARMACEUTICAL FORMULATION OF DECITABINE |
| Payment date | Validity (years) | Amount | |
| 2024-11-22 | 347.00 EUR |